108 related articles for article (PubMed ID: 10352360)
1. Cell cycle regulatory proteins in glomerular disease.
Shankland SJ; Al'Douahji M
Exp Nephrol; 1999; 7(3):207-11. PubMed ID: 10352360
[TBL] [Abstract][Full Text] [Related]
2. The cyclin kinase inhibitor p21WAF1, CIP1 is increased in experimental diabetic nephropathy: potential role in glomerular hypertrophy.
Kuan CJ; al-Douahji M; Shankland SJ
J Am Soc Nephrol; 1998 Jun; 9(6):986-93. PubMed ID: 9621281
[TBL] [Abstract][Full Text] [Related]
3. Cyclins and the cyclin-kinase system--their potential roles in nephrology.
Terada Y; Inoshita S; Nakashima O; Kuwahara M; Sasaki S; Marumo F
Nephrol Dial Transplant; 1998 Aug; 13(8):1913-6. PubMed ID: 9719135
[TBL] [Abstract][Full Text] [Related]
4. Cell cycle and glomerular disease: a minireview.
Marshall CB; Shankland SJ
Nephron Exp Nephrol; 2006; 102(2):e39-48. PubMed ID: 16179806
[TBL] [Abstract][Full Text] [Related]
5. Cell cycle regulatory proteins in renal disease: role in hypertrophy, proliferation, and apoptosis.
Shankland SJ; Wolf G
Am J Physiol Renal Physiol; 2000 Apr; 278(4):F515-29. PubMed ID: 10751212
[TBL] [Abstract][Full Text] [Related]
6. Mechanical stress reduces podocyte proliferation in vitro.
Petermann AT; Hiromura K; Blonski M; Pippin J; Monkawa T; Durvasula R; Couser WG; Shankland SJ
Kidney Int; 2002 Jan; 61(1):40-50. PubMed ID: 11786083
[TBL] [Abstract][Full Text] [Related]
7. Differential expression of cyclin-dependent kinase inhibitors in human glomerular disease: role in podocyte proliferation and maturation.
Shankland SJ; Eitner F; Hudkins KL; Goodpaster T; D'Agati V; Alpers CE
Kidney Int; 2000 Aug; 58(2):674-83. PubMed ID: 10916090
[TBL] [Abstract][Full Text] [Related]
8. Roles of E2F1 in mesangial cell proliferation in vitro.
Inoshita S; Terada Y; Nakashima O; Kuwahara M; Sasaki S; Marumo F
Kidney Int; 1999 Dec; 56(6):2085-95. PubMed ID: 10594784
[TBL] [Abstract][Full Text] [Related]
9. The cyclin kinase inhibitor p21CIP1/WAF1 limits glomerular epithelial cell proliferation in experimental glomerulonephritis.
Kim YG; Alpers CE; Brugarolas J; Johnson RJ; Couser WG; Shankland SJ
Kidney Int; 1999 Jun; 55(6):2349-61. PubMed ID: 10354282
[TBL] [Abstract][Full Text] [Related]
10. High glucose-induced hypertrophy of mesangial cells requires p27(Kip1), an inhibitor of cyclin-dependent kinases.
Wolf G; Schroeder R; Zahner G; Stahl RA; Shankland SJ
Am J Pathol; 2001 Mar; 158(3):1091-100. PubMed ID: 11238057
[TBL] [Abstract][Full Text] [Related]
11. The role of cell cycle proteins in Glomerular disease.
Griffin SV; Pichler R; Wada T; Vaughan M; Durvasula R; Shankland SJ
Semin Nephrol; 2003 Nov; 23(6):569-82. PubMed ID: 14631565
[TBL] [Abstract][Full Text] [Related]
12. The cyclin kinase inhibitor p21WAF1/CIP1 is required for glomerular hypertrophy in experimental diabetic nephropathy.
Al-Douahji M; Brugarolas J; Brown PA; Stehman-Breen CO; Alpers CE; Shankland SJ
Kidney Int; 1999 Nov; 56(5):1691-9. PubMed ID: 10571777
[TBL] [Abstract][Full Text] [Related]
13. Cyclins D1 and D2 mediate myc-induced proliferation via sequestration of p27(Kip1) and p21(Cip1).
Perez-Roger I; Kim SH; Griffiths B; Sewing A; Land H
EMBO J; 1999 Oct; 18(19):5310-20. PubMed ID: 10508164
[TBL] [Abstract][Full Text] [Related]
14. Cell cycle inhibitors (p27Kip1 and p21CIP1) cause hypertrophy in LLC-PK1 cells.
Terada Y; Inoshita S; Nakashima O; Tamamori M; Ito H; Kuwahara M; Sasaki S; Marumo F
Kidney Int; 1999 Aug; 56(2):494-501. PubMed ID: 10432388
[TBL] [Abstract][Full Text] [Related]
15. The subcellular localization of cyclin dependent kinase 2 determines the fate of mesangial cells: role in apoptosis and proliferation.
Hiromura K; Pippin JW; Blonski MJ; Roberts JM; Shankland SJ
Oncogene; 2002 Mar; 21(11):1750-8. PubMed ID: 11896606
[TBL] [Abstract][Full Text] [Related]
16. Molecular mechanisms underlying interferon-alpha-induced G0/G1 arrest: CKI-mediated regulation of G1 Cdk-complexes and activation of pocket proteins.
Sangfelt O; Erickson S; Castro J; Heiden T; Gustafsson A; Einhorn S; Grandér D
Oncogene; 1999 May; 18(18):2798-810. PubMed ID: 10362250
[TBL] [Abstract][Full Text] [Related]
17. Differential changes of CDK activities in glomeruli and tubules during the active DNA synthetic period after ischemic injury.
Park SK; Kim W; Lee CH; Koh GY
Nephron; 2000 Nov; 86(3):306-14. PubMed ID: 11096288
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin II-induced hypertrophy of proximal tubular cells requires p27Kip1.
Wolf G; Jablonski K; Schroeder R; Reinking R; Shankland SJ; Stahl RA
Kidney Int; 2003 Jul; 64(1):71-81. PubMed ID: 12787397
[TBL] [Abstract][Full Text] [Related]
19. Glucocorticoids stimulate p21(CIP1) in mesangial cells and in anti-GBM glomerulonephritis.
Terada Y; Okado T; Inoshita S; Hanada S; Kuwahara M; Sasaki S; Yamamoto T; Marumo F
Kidney Int; 2001 May; 59(5):1706-16. PubMed ID: 11318941
[TBL] [Abstract][Full Text] [Related]
20. Cell cycle regulatory proteins in podocyte health and disease.
Marshall CB; Shankland SJ
Nephron Exp Nephrol; 2007; 106(2):e51-9. PubMed ID: 17570940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
